Get the Stockscreener App
51.23
2.01%
-1.05
Mirum Pharmaceuticals Inc Stock (MIRM) Latest News
Golden State Equity Partners Has $801,000 Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat
Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $57.10 - MarketBeat
Genomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis - PR Web
SG Americas Securities LLC Has $289,000 Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells $51,306.08 in Stock - MarketBeat
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Peter Radovich Sells 2,627 Shares - MarketBeat
Christopher Peetz Sells 9,102 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock - MarketBeat
Mirum Pharmaceuticals president sells $126,680 in stock - MSN
Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 1-Year HighTime to Buy? - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) shareholder returns have been solid, earning 192% in 5 years - Simply Wall St
Major Insider Stock Sales at Mirum Pharmaceuticals! - TipRanks
Mirum Pharmaceuticals president sells $126,680 in stock By Investing.com - Investing.com Canada
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year HighShould You Buy? - MarketBeat
Mirum Pharmaceuticals stock soars to all-time high of $49.59 - MSN
Mirum Pharmaceuticals stock soars to all-time high of $49.59 By Investing.com - Investing.com UK
Recent Price Trend in Mirum Pharmaceuticals (MIRM) is Your Friend, Here's Why - Yahoo Finance
Mirum Pharmaceuticals stock soars to all-time high of $48.94 - MSN
Mirum Pharmaceuticals SVP sells shares worth $43,227 By Investing.com - Investing.com Australia
Insider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells 902 Shares of Stock - MarketBeat
Christopher Peetz Sells 6,837 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock - MarketBeat
Mirum Pharmaceuticals CEO sells shares worth $327,658 By Investing.com - Investing.com Australia
Mirum Pharmaceuticals SVP sells shares worth $43,227 - Investing.com India
Mirum Pharmaceuticals CEO sells shares worth $327,658 - Investing.com India
Mirum Pharmaceuticals president sells $152,256 in stock By Investing.com - Investing.com Canada
(MIRM) Long Term Investment Analysis - Stock Traders Daily
Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock? - MSN
FY2024 EPS Estimates for MIRM Increased by Leerink Partnrs - MarketBeat
Leerink Partnrs Issues Optimistic Estimate for MIRM Earnings - Defense World
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 12-Month HighShould You Buy? - MarketBeat
As Biotech Trade Gets Wonky, I'm Eyeing Two Clinical-Stage Companies - RealMoney
Cantor Fitzgerald Comments on MIRM FY2025 Earnings - Defense World
Mirum Pharmaceuticals stock soars to all-time high of $48.94 By Investing.com - Investing.com South Africa
Brokers Issue Forecasts for MIRM FY2025 Earnings - MarketBeat
Mirum Pharmaceuticals' chief medical officer sells $319,598 in stock By Investing.com - Investing.com Australia
Joanne Quan Sells 6,969 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock - MarketBeat
Biliary Atresia Market to Expand Significantly by 2034, States DelveInsight Report | Albireo Pharma, Mirum Pharmaceuticals - Barchart
Mirum Pharmaceuticals' chief medical officer sells $319,598 in stock - MSN
Financial Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) & Eyenovia (NASDAQ:EYEN) - Defense World
MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results - MSN
(MIRM) Investment Report - Stock Traders Daily
Hennion & Walsh Asset Management Inc. Purchases 29,545 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):